Phase 2: Pain Management Completed Phase 1 / 2 Trials for Bupivacaine (DB00297)

IndicationStatusPhase
DBCOND0117281 (Phase 2: Pain Management)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02654860Dose-finding Study of Intrathecal Paracetamol Administered Immediately Before Spinal AnaesthesiaSupportive Care